FI111721B - Uusi kondensoitu indaanijohdannainen ja sen farmaseuttisesti hyväksyttävä suola - Google Patents

Uusi kondensoitu indaanijohdannainen ja sen farmaseuttisesti hyväksyttävä suola Download PDF

Info

Publication number
FI111721B
FI111721B FI960280A FI960280A FI111721B FI 111721 B FI111721 B FI 111721B FI 960280 A FI960280 A FI 960280A FI 960280 A FI960280 A FI 960280A FI 111721 B FI111721 B FI 111721B
Authority
FI
Finland
Prior art keywords
group
substituted
lower alkyl
ring
compound
Prior art date
Application number
FI960280A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI960280A (fi
FI960280A0 (fi
Inventor
Yuji Yamada
Tetsuji Asao
Keisuke Ishida
Shinji Okazaki
Teruhiro Utsugi
Motoji Wakida
Masato Washinosu
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of FI960280A0 publication Critical patent/FI960280A0/fi
Publication of FI960280A publication Critical patent/FI960280A/fi
Application granted granted Critical
Publication of FI111721B publication Critical patent/FI111721B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI960280A 1994-05-20 1996-01-19 Uusi kondensoitu indaanijohdannainen ja sen farmaseuttisesti hyväksyttävä suola FI111721B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP10719094 1994-05-20
JP10719094 1994-05-20
JP9500944 1995-05-18
PCT/JP1995/000944 WO1995032187A1 (fr) 1994-05-20 1995-05-18 Nouveau derive d'indane fusionne et sel dudit derive acceptable pharmaceutiquement

Publications (3)

Publication Number Publication Date
FI960280A0 FI960280A0 (fi) 1996-01-19
FI960280A FI960280A (fi) 1996-03-18
FI111721B true FI111721B (fi) 2003-09-15

Family

ID=14452758

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960280A FI111721B (fi) 1994-05-20 1996-01-19 Uusi kondensoitu indaanijohdannainen ja sen farmaseuttisesti hyväksyttävä suola

Country Status (21)

Country Link
US (3) US5733918A (xx)
EP (1) EP0713870B1 (xx)
KR (1) KR100190732B1 (xx)
CN (1) CN1131216C (xx)
AT (1) ATE203236T1 (xx)
AU (1) AU685631B2 (xx)
CA (1) CA2167382C (xx)
DE (1) DE69521770T2 (xx)
DK (1) DK0713870T3 (xx)
ES (1) ES2158109T3 (xx)
FI (1) FI111721B (xx)
GR (1) GR3036795T3 (xx)
HU (1) HU218308B (xx)
IL (1) IL113778A (xx)
NO (1) NO305555B1 (xx)
NZ (1) NZ285448A (xx)
PT (1) PT713870E (xx)
RU (1) RU2124017C1 (xx)
TW (1) TW440562B (xx)
WO (1) WO1995032187A1 (xx)
ZA (1) ZA954077B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3141148B2 (ja) * 1995-08-08 2001-03-05 大鵬薬品工業株式会社 縮合インダン誘導体及びその塩
US20030096833A1 (en) * 2001-08-31 2003-05-22 Jagtap Prakash G. Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof
US6956035B2 (en) * 2001-08-31 2005-10-18 Inotek Pharmaceuticals Corporation Isoquinoline derivatives and methods of use thereof
BR0213122A (pt) * 2001-10-05 2004-09-21 Hoffmann La Roche Compostos policìclicos tendo atividade antitumoral
US6946472B2 (en) * 2002-04-30 2005-09-20 Hoffman-La Roche Inc. Polycyclic compounds exhibiting anti-tumor activities
CL2004000366A1 (es) * 2003-02-26 2005-01-07 Pharmacia Corp Sa Organizada B USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
WO2005009398A2 (en) * 2003-02-28 2005-02-03 Inotek Pharmaceuticals Corporation Tetracyclic benzamide derivatives and methods of use thereof
AU2005216530A1 (en) * 2004-02-26 2005-09-09 Inotek Pharmaceuticals Corporation Tetracyclic Lactam Derivatives and uses thereof
EA200601558A1 (ru) * 2004-02-26 2007-08-31 Инотек Фармасьютикалз Корпорейшн Производные изохинолинов и способы их использования
US20060019980A1 (en) * 2004-06-16 2006-01-26 Inotek Pharmaceutical, Corp. Methods for treating or preventing erectile dysfunction or urinary incontinence
WO2006091769A1 (en) * 2005-02-24 2006-08-31 Janssen Pharmaceutica N.V. Novel quinoline derivatives as potassium ion channel openers
JP2008531562A (ja) * 2005-02-25 2008-08-14 イノテック ファーマシューティカルズ コーポレイション 四環アミノ化合物および四環カルボキサミド化合物およびこれらの使用法
CA2597576A1 (en) * 2005-02-25 2006-09-08 Inotek Pharmaceuticals Corporation Isoquinoline compounds and methods of use thereof
WO2006093677A1 (en) * 2005-02-25 2006-09-08 Inotek Pharmaceuticals Corporation Tetracyclic sulfonamide compounds and methods of use thereof
CN101316592A (zh) * 2005-08-24 2008-12-03 伊诺泰克制药公司 茚并异喹啉酮类似物及其用法
JP2010520220A (ja) * 2007-02-28 2010-06-10 イノテック ファーマシューティカルズ コーポレイション インデノイソキノリノン類似体およびその使用方法
CN103102304B (zh) * 2013-01-19 2015-03-11 安徽师范大学 N-磺酰基取代四氢异喹啉衍生物的制备方法
WO2015025936A1 (ja) 2013-08-22 2015-02-26 大鵬薬品工業株式会社 新規キノリン置換化合物
JOP20190073A1 (ar) 2016-10-31 2019-04-07 Taiho Pharmaceutical Co Ltd مثبط انتقائي لمستقبل عامل نمو بشروي (egfr) لطافر إدخال exon 20
PL3677266T3 (pl) 2017-09-01 2024-07-01 Taiho Pharmaceutical Co., Ltd. Selektywny inhibitor egfr z mutacją w eksonie 18 i/lub eksonie 21

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223506A (en) * 1991-06-04 1993-06-29 Glaxo Inc. Cyclic antitumor compounds

Also Published As

Publication number Publication date
EP0713870B1 (en) 2001-07-18
ATE203236T1 (de) 2001-08-15
HUT75651A (en) 1997-05-28
TW440562B (en) 2001-06-16
ZA954077B (en) 1996-01-19
US6028079A (en) 2000-02-22
WO1995032187A1 (fr) 1995-11-30
HU218308B (en) 2000-07-28
DK0713870T3 (da) 2001-09-24
DE69521770D1 (de) 2001-08-23
NZ285448A (en) 1997-11-24
CA2167382C (en) 1999-08-31
FI960280A (fi) 1996-03-18
US5733918A (en) 1998-03-31
IL113778A (en) 1999-09-22
DE69521770T2 (de) 2002-05-23
PT713870E (pt) 2001-11-30
CA2167382A1 (en) 1995-11-30
EP0713870A1 (en) 1996-05-29
RU2124017C1 (ru) 1998-12-27
KR960703864A (ko) 1996-08-31
AU685631B2 (en) 1998-01-22
US5710162A (en) 1998-01-20
FI960280A0 (fi) 1996-01-19
CN1131216C (zh) 2003-12-17
CN1130903A (zh) 1996-09-11
NO960239D0 (no) 1996-01-19
NO305555B1 (no) 1999-06-21
ES2158109T3 (es) 2001-09-01
IL113778A0 (en) 1995-08-31
NO960239L (no) 1996-03-18
GR3036795T3 (en) 2002-01-31
AU2454295A (en) 1995-12-18
EP0713870A4 (en) 1996-12-18
KR100190732B1 (ko) 1999-06-01

Similar Documents

Publication Publication Date Title
FI111721B (fi) Uusi kondensoitu indaanijohdannainen ja sen farmaseuttisesti hyväksyttävä suola
KR102473481B1 (ko) 강력하고 선택적인 rock 억제제로서의 락탐, 시클릭 우레아 및 카르바메이트, 및 트리아졸론 유도체
KR102491994B1 (ko) Rock의 억제제로서의 스피로락탐
US5786355A (en) 4,6-diarylpyrimidine derivatives and salts thereof
NZ272516A (en) Pyrrolopyridine and oxazolopyridine derivatives and medicaments thereof
WO2004033423A2 (en) Anticancer compounds
KR870001362B1 (ko) 테트라하이드로 이미다조퀴나졸리논 유도체의 제조방법
JP3643916B2 (ja) 新規な縮合インデン誘導体又はその塩
EP0670313A1 (en) Spiro compounds, their production and use
DE68910593T2 (de) Chinolinoncarbonsäuren.
US5362736A (en) Isoquinoline derivatives
Hutchinson et al. Synthesis and properties of bioactive 2-and 3-amino-8-methyl-8H-quino [4, 3, 2-kl] acridine and 8, 13-dimethyl-8 H-quino [4, 3, 2-kl] acridinium salts
US5763453A (en) Condensed indan derivatives and salts thereof
US5278158A (en) Oxazinobenzazole compounds
US4946840A (en) Benzazepine and benzothiazepine derivatives
JP2840796B2 (ja) 新規な縮合インダン誘導体及びその薬学的に許容される塩
DE19901306A1 (de) Neue Oxazolidinone
DE69213049T2 (de) Isoquinolinderivate
EP0522887A1 (en) Imidazoles as ACAT- and thromboxane TxA2 inhibitors
JPH02229165A (ja) カルボスチリル誘導体
CA1234809A (en) Fused aromatic oxazepinones and sulfur analogs thereof in a method of counteracting histamine
WO2003078646A2 (en) Aza-thioxanthenones with antitumor activity
WO2003078647A2 (en) Aza-benzothiopyranoindazoles with antitumor activity
JPS6185384A (ja) 新規化合物，その製法及びそれを含む医薬組成物
JPH07291935A (ja) スピロ化合物、その製造法および剤